Search

Your search keyword '"Spinal muscular atrophy -- Care and treatment"' showing total 312 results
Start Over Descriptor "Spinal muscular atrophy -- Care and treatment"
312 results on '"Spinal muscular atrophy -- Care and treatment"'

302. Indoprofen Increases SMN

Subjects
Spinal muscular atrophy -- Care and treatment, Spinal muscular atrophy -- Drug therapy, Spinal muscular atrophy -- Research, Anti-inflammatory drugs -- Health aspects, Anti-inflammatory drugs -- Usage, Consumer news and advice, Health
Published
2005

303. Drug Screen Under Way

Subjects
Spinal muscular atrophy -- Genetic aspects, Spinal muscular atrophy -- Care and treatment, Spinal muscular atrophy -- Research, Consumer news and advice, Health
Published
2005

304. Lentivirus Vector Delivers Genes to SMA Mice

Subjects
Gene therapy -- Research, Spinal muscular atrophy -- Care and treatment, Spinal muscular atrophy -- Genetic aspects, Spinal muscular atrophy -- Research, Consumer news and advice, Health
Published
2005

305. Beating the odds

Author

Lee, Robert W.

Subjects
Spinal muscular atrophy -- Case studies, Spinal muscular atrophy -- Care and treatment
Abstract

Spinal muscular atrophy (SMA) is an inherited disease that causes progressive muscle deterioration and weakness. There is currently no treatment for the usually-fatal disorder. SMA Type I, the severest form, […]

Published
2003

308. Isis Pharmaceuticals Initiates Phase 1b/2a Study Of ISIS-SMNRx In Patients With Spinal Muscular Atrophy

Subjects
Ionis Pharmaceuticals, Inc. -- Product development, Medical research, Medicine, Experimental, Spinal muscular atrophy -- Care and treatment, Pharmaceutical industry -- Product development, Health
Abstract

By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 1b/2a study evaluating ISIS-SMNRx in children with spinal [...]

Published
2012

309. Isis Initiates Phase 1 Clinical Study of ISIS-SMNRx in Patients With Spinal Muscular Atrophy

Subjects
Ionis Pharmaceuticals, Inc. -- Product development, Medical research, Medicine, Experimental, Clinical trials, Spinal muscular atrophy -- Care and treatment, Pharmaceutical industry -- Product development, Health
Abstract

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced that it has initiated a Phase 1 study of ISIS-SMNRx in patients with spinal muscular atrophy (SMA). SMA is a severe motor-neuron disease that [...]

Published
2012

310. Neurodegeneration: methods to improve HDAC inhibitor

Subjects
Spinal muscular atrophy -- Care and treatment, Spinal muscular atrophy -- Genetic aspects, Pharmaceutical industry -- Product enhancement, Drugs -- Product enhancement, Product enhancement, Biotechnology industry
Abstract

In a paper in the Feb. 22, 2007 issue of The Journal of Clinical Investigation, researchers from the National Institute of Neurological Diseases and Stroke and the Institute of Cell [...]

Published
2007

311. French researchers encouraged by gene therapy results in mice

Author

Etheridge, James

Subjects
Gene therapy -- Testing, Spinal muscular atrophy -- Care and treatment, Biotechnology industry, Business, Business, international
Abstract

PARIS -- Researchers at France's National Institute for Health and Medical Research (INSERM) obtained 'encouraging' results from a trial in mice of a gene therapy for spinal muscular atrophy. The [...]

Published
2003

312. Motor neuron disease Orphan Drug

Subjects
Syntex Laboratories Inc. -- Joint ventures, Synergen Inc. -- Joint ventures, Neuromuscular diseases -- Care and treatment, Pharmaceutical industry -- Joint ventures, Amyotrophic lateral sclerosis -- Care and treatment, Atrophy, Muscular -- Care and treatment, Bulbar paralysis -- Care and treatment, Spinal muscular atrophy -- Care and treatment, Orphan drugs -- Reports, Economics, Health care industry, High technology industry
Published
1992

Catalog

Books, media, physical & digital resources
See catalog results